Related references
Note: Only part of the references are listed.Structure and biosynthesis of fumosorinone, a new protein tyrosine phosphatase 1B inhibitor firstly isolated from the entomogenous fungus Isaria fumosorosea
Linxia Liu et al.
FUNGAL GENETICS AND BIOLOGY (2015)
PTPN11/Shp2 overexpression enhances liver cancer progression and predicts poor prognosis of patients
Tao Han et al.
JOURNAL OF HEPATOLOGY (2015)
Fumosorinone, a novel PTP1B inhibitor, activates insulin signaling in insulin-resistance HepG2 cells and shows anti-diabetic effect in diabetic KKAy mice
Zhi-Qin Liu et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2015)
Tyrosine phosphatase SHP2 increases cell motility in triple-negative breast cancer through the activation of SRC-family kinases
N. Sausgruber et al.
ONCOGENE (2015)
Therapeutic Potential of Targeting the Oncogenic SHP2 Phosphatase
Li-Fan Zeng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Upregulation of Src homology phosphotyrosyl phosphatase 2 (Shp2) expression in oral cancer and knockdown of Shp2 expression inhibit tumor cell viability and invasion in vitro
Hongjun Xie et al.
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY (2014)
Identification of Cryptotanshinone as an Inhibitor of Oncogenic Protein Tyrosine Phosphatase SHP2 (PTPN11)
Wei Liu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Targeting Protein Tyrosine Phosphatase SHP2 for the Treatment of PTPN11-Associated Malignancies
Bing Yu et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Ptpn11 deletion in a novel progenitor causes metachondromatosis by inducing hedgehog signalling
Wentian Yang et al.
NATURE (2013)
Low expression of SHP-2 is associated with less favorable prostate cancer outcomes
Helena Tassidis et al.
TUMOR BIOLOGY (2013)
Expression of SHP2 and Related Markers in Non-Small Cell Lung Cancer: A Tissue Microarray Study of 80 Cases
Chunlan Tang et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2013)
The tumor suppressor role of Src homology phosphotyrosine phosphatase 2 in hepatocellular carcinoma
Chengying Jiang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
Tyrosine phosphatase SHP2 promotes breast cancer progression and maintains tumor-initiating cells via activation of key transcription factors and a positive feedback signaling loop
Nicola Aceto et al.
NATURE MEDICINE (2012)
Akt phosphorylation on Thr308 but not on Ser473 correlates with Akt protein kinase activity in human non-small cell lung cancer
E. E. Vincent et al.
BRITISH JOURNAL OF CANCER (2011)
Ptpn11/Shp2 Acts as a Tumor Suppressor in Hepatocellular Carcinogenesis
Emilie A. Bard-Chapeau et al.
CANCER CELL (2011)
SHP2 Is a Target of the Immunosuppressant Tautomycetin
Sijiu Liu et al.
CHEMISTRY & BIOLOGY (2011)
Akt Requires Glucose Metabolism to Suppress Puma Expression and Prevent Apoptosis of Leukemic T Cells
Jonathan L. Coloff et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
AST1306, A Novel Irreversible Inhibitor of the Epidermal Growth Factor Receptor 1 and 2, Exhibits Antitumor Activity Both In Vitro and In Vivo
Hua Xie et al.
PLOS ONE (2011)
SPARCL1, Shp2, MSH2, E-cadherin, p53, ADCY-2 and MAPK are prognosis-related in colorectal cancer
Shu-Jing Yu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Inhibition of cellular Shp2 activity by a methyl ester analog of SPI-112
Liwei Chen et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Protein tyrosine phosphatases as drug targets: strategies and challenges of inhibitor development
Alastair J. Barr
FUTURE MEDICINAL CHEMISTRY (2010)
Paxillin Regulates Androgen- and Epidermal Growth Factor-induced MAPK Signaling and Cell Proliferation in Prostate Cancer Cells
Aritro Sen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Salicylic Acid Based Small Molecule Inhibitor for the Oncogenic Src Homology-2 Domain Containing Protein Tyrosine Phosphatase-2 (SHP2)
Xian Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Protein tyrosine phosphatase SHP-2: A proto-oncogene product that promotes Ras activation
Takashi Matozaki et al.
CANCER SCIENCE (2009)
The protein tyrosine phosphatase SHP-2 is required for EGFRvIII oncogenic transformation in human glioblastoma cells
Yi Zhan et al.
EXPERIMENTAL CELL RESEARCH (2009)
A Conserved Mechanism for Control of Human and Mouse Embryonic Stem Cell Pluripotency and Differentiation by Shp2 Tyrosine Phosphatase
Dongmei Wu et al.
PLOS ONE (2009)
The tyrosine phosphatase Shp2 (PTPN11) in cancer
Gordon Chan et al.
CANCER AND METASTASIS REVIEWS (2008)
Isolation of a distinct class of gain-of-function SHP-2 mutants with oncogenic RAS-like transforming activity from solid tumors
D. Miyamoto et al.
ONCOGENE (2008)
Specific inhibitors of the protein tyrosine phosphatase Shp2 identified by high-throughput docking
Klaus Hellmuth et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The role of Shp2 (PTPN11) in cancer
M. Golam Mohi et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2007)
PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase
Rebecca J. Chan et al.
BLOOD (2007)
Discovery of a novel Shp2 protein tyrosine phosphatase inhibitor
Liwei Chen et al.
MOLECULAR PHARMACOLOGY (2006)
Concerted functions of Gab1 and Shp2 in liver regeneration and hepatoprotection
Emilie A. Bard-Chapeau et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Protein-tyrosine phosphatases and cancer
A Östman et al.
NATURE REVIEWS CANCER (2006)
A novel role for Gab1 and SHP2 in epidermal growth factor-induced ras activation
A Montagner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Roles of Gab1 and SHP2 in paxillin tyrosine dephosphorylation and Src activation in response to epidermal growth factor
Y Ren et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The role of protein tyrosine phosphatase 1B in Ras signaling
N Dube et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Shp2 regulates Src family kinase activity and Ras/Erk activation by controlling Csk recruitment
SQ Zhang et al.
MOLECULAR CELL (2004)
c-Src and cooperating partners in human cancer
R Ishizawar et al.
CANCER CELL (2004)
Activating mutations of the Noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia
M Bentires-Alj et al.
CANCER RESEARCH (2004)
PI3K/Akt and apoptosis: size matters
TF Franke et al.
ONCOGENE (2003)
Molecular mechanism for a role of SHP2 in epidermal growth factor receptor signaling
YM Agazie et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Gab1 is an integrator of cell death versus cell survival signals in oxidative stress
M Holgado-Madruga et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling
BG Neel et al.
TRENDS IN BIOCHEMICAL SCIENCES (2003)
ERK negatively regulates the epidermal growth factor-mediated interaction of Gab1 and the phosphatidylinositol 3-kinase
CF Yu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Regulation of the mitogen-activated protein kinase signaling pathway by SHP2
JM Cunnick et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Structural and evolutionary relationships among protein tyrosine phosphatase domains
JN Andersen et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors
CJ Wu et al.
ONCOGENE (2001)
Phosphotyrosines 627 and 659 of Gab1 constitute a bisphosphoryl tyrosine-based activation motif (BTAM) conferring binding and activation of SHP2
JM Cunnick et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Ras and Rho GTPases: A family reunion
D Bar-Sagi et al.
CELL (2000)
Share Paper
